Hypertension, magnesium deficiency and intima media thickness;Hypertonie, magnesiummangel und intima-media-dicke

Nieren- und Hochdruckkrankheiten

Volumn 35, Issue 3, 2006, Pages 99-102

  Kisters, K ^a,c   Al Tayar, H ^a   Kozianka, J ^a   Funke, C ^a   Franitza, P ^a   Gremmler, B ^b   Wessels, F ^a   Liebscher, H ^c   Tokmak, F ^c   Hausberg, M ^c   Buntzel J ^c  

^a ST ANNA HOSPITAL   (Germany)

^b Marien Hospital Bottrop gGmbH   (Germany)

^c Arbeitskreis Trace Elements and Electrolytes (AKTE eV)   (Germany)

Author keywords

Arteriosclerosis; Essential hypertension; Intima media thickness; Magnesium

Indexed keywords

CALCIUM ANTAGONIST; MAGNESIUM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIOSCLEROSIS; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; COMMON CAROTID ARTERY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; INTIMA MEDIA THICKNESS; MAGNESIUM DEFICIENCY; MALE; PATHOGENESIS; SUPPLEMENTATION; THICKNESS;

EID: 33645380126     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: 10.5414/nhp35099     Document Type: Article

References (32)

1. Boutouyrie P., AI Tropeano, R. Asmar, I. Gautier, A. Bentos, P. Lacolley, S. Laurent: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39, 10-15 (2002).
2. Durlach J. : Magnesium in clinical practice. John Libbey, London 1988, 360 ff.
3. Durlach J., V. Durlach, Y. Rayssiguier, M. Bara, A. Guiet-Bara: Magnesium and blood pressure. II. Clinical studies. Magnes. Res. 5, 147-153 (1992).
4. Kario K., K. Ishikawa, K. Eguchi, M. Morinari, S. Hoshide, S. Ishikawa, K. Shimada: Sleep pulse pressure and awake mean pressure as independent predictors for stroke in older hypertensive patients. Am. J. Hypertens. 5, 439-445 (2004).
5. Kisters K., C. Spieker, M. Tepel, W. Zidek: New data about effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes. Res. 4. 355-360 (1993).
6. ++ concentrations in a subgroup of hypertensives-cell models for the pathogenesis of primary hypertension. J. Hum. Hypertens. 11, 367-372 (1997).
7. ++ concentrations in a subgroup of hypertensives. Membrane model for the pathogenesis of primary hypertension. Am. J. Hypertens. 11, 1390-1993 (1998).
8. + exchange in vascular smooth muscle cells from SHR. Clin. Sci. 95, 583-587 (1998).
9. Kisters K., M. Barenbrock, F. Louwen, M. Hausberg, K.H. Rahn, M. Kosch: Membrane, intracellular and plasma magnesium and calcium concentrations in preeclampsia. Am. J. Hypertens. 13, 765-769 (2000).
10. Kisters K., E.R. Krefting, M. Hausberg, K. Kohnert, A. Honig, D. Bettin: Importance of decreased intracellular phosphate and magnesium concentrations and reduced ATPase activities in SHR. Magnes. Res. 13, 183-188 (2000).
11. Kisters K., M. Hausberg, M. Kosch: Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxy corticosterone acetate-induced hypertension in rats. J. Hypertens. 1, 161-162 (2001).
12. Kisters K., F. Wessels, F. Tokmak, H. Küper, M. Hausberg, E.R. Krefting: Increased arterial smooth muscle cell calcium and decreased magnesium concentrations in spontaneously hypertensive rats (SHR) and in human hypertension. Trace Elem. Electrolytes 21, 201 (2003).
13. Kisters K., F. Wesels, F. Tokmak, E.R. Krefting, B. Gremmler, M. Kosch, M. Hausberg: Early-onset increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in SHR versus WKY. Magnes. Res. 17, 264-269 (2004).
14. Kisters K., F. Wessels, H. Küper, F. Tokmak, E.R. Krefting, B. Gremmler, M. Kosch, M. Barenbrock. M. Hausberg: Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in spontaneously hypertensive rats versus Wistar-Kyoto rats: relation to arteriosclerosis. Am J. Hypertens 17, 59-62 (2004).
15. Kisters K., F. Tokmak, B. Gremmler, M. Kosch, M. Hausberg: Increased calcium/magnesium ratio in young and old SHR - pathogenetic factor in the development of hypertension and vascular fibrosis. Am. J. Hypertens. 18, 1136 (2005).
16. Kisters K., B. Gremmler, M. Hausberg: Magnesium and arterial stiffness. Hypertension. Epub Dec. (2005).
17. Kisters K., O. Hoffmann, M. Hausberg, C. Funke, J. Kozianka, B. Gremmler: Magnesium und Pulsdruck bei Hypertonie. Nieren-Hochdruckkrh. 10, 455-457 (2005).
18. Kisters K., B. Gremmler, M. Hausberg: Pulse pressure, plasma magnesium status, and antihypertensive therapy. Am. J. Hypertens. 18, 1136 (2005).
19. Kisters K., O. Hoffmann, B. Gremmler, M. Hausberg: Plasma magnesium defiency ist correlated to pulse pressure values in essential hypertension - influence of a metabolic syndrome. Am. J. Hypertens. 18, 215A(2005).
20. Kisters K., H. Al-Tayar, M. Hausberg: Magnesiummangel und Intima-Media-Dicke bei Hypertonie. DMW 130, S148 (2005).
21. Kisters K., B. Gremmler, M. Hausberg: Preventing pregnancy-induced hypertension: the role of calcium und magnesium. J. Hypertens. 24, 2010 (2006).
22. Kisters, K., F. Wessels, E.R. Krefting, B. Gremmler, M. Quang Nguyen, J. Kozianka, M. Hausberg: Early onset of a decreased intracellular magnesium and phosphate concentration in smooth muscle cells of SHR. Magnes. Res. in press (2006).
23. Kisters, K., B. Gremmler, J. Kozianka, M. Hausberg: Magnesium deficiency and diabetes mellitus. Clin. Nephrol. 65, 77-78 (2006).
24. Laurent, S., S. Katsahian, C. Fassot, AI. Tropeano, I, Gautier, B. Laloux, P. Boutouyrie: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34, 1203-1206 (2003).
25. Laurent S., P. Boutouyrie, P. Lacolley: Structural and genetic bases of arterial stiffness. Hypertension 45, 1050-1055 (2005).
26. Resnick L.M., J.H. Laragh, J.E. Sealey, M.H. Aldemann: Divalent cations in essential hypertension: relations between serum ionised calcium magnesium and plasma renin activity. N. Engl. J. Med. 309, 888-891 (1983).
27. Resnick L.M., R.K. Gupta, J.H. Laragh: Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc. Natl. Acad. Sci. USA 81, 6511-6515 (1984).
28. Touyz R.M., F.J. Milne: Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. Am. J. Hypertens. 12, 757-765 (1999).
29. ++ uptake channels. TRPM6 and TRPM7 in vascular smooth muscle cells from WKY and SHR - differential regulation by aldosterone and angiotensin II. Am. J. Hypertens. 5, 176 (2004).
30. Turnbull F.: Effects of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials Lancet 362, 1527-1535 (2003).
31. Zanchetti A., M.G. Bond, M. Hennig et al: Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomised, double-blind, long-term trial. Circulation 106, 2422-2427 (2002).
32. Zimlichman R., M. Shargorodsky, M. Boaz et al: Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 systems: reliability, repeatability, and establishment of normal values for healthy European population - the seven European sites study (SESS). Am. J. Hypertens. 18, 65-71 (2005).